| COVID 19: a clue from innate immunity D Birra, M Benucci, L Landolfi, A Merchionda, G Loi, P Amato, G Licata, ... Immunologic research 68, 161-168, 2020 | 172 | 2020 |
| Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib G Licata, A Gambardella, V Tancredi, G Calabrese, A De Rosa, R Alfano, ... Journal of the European Academy of Dermatology and Venereology 36 (2), e150-e152, 2022 | 36 | 2022 |
| Drug survival of interleukin (IL)‑17 and IL‑23 inhibitors for the treatment of psoriasis: a retrospective multi‑country, multicentric cohort study T Torres, L Puig, R Vender, J Yeung, JM Carrascosa, S Piaserico, ... American Journal of Clinical Dermatology 23 (6), 891-904, 2022 | 33 | 2022 |
| Dual efficacy of upadacitinib in 2 patients with concomitant severe atopic dermatitis and alopecia areata A Gambardella, G Licata, G Calabrese, A De Rosa, R Alfano, ... Dermatitis 32 (1), e85-e86, 2021 | 29 | 2021 |
| Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature G Licata, C Scharf, A Ronchi, S Pellerone, G Argenziano, P Verolino, ... Clinical, Cosmetic and Investigational Dermatology, 1435-1447, 2021 | 19 | 2021 |
| Dose adjustment of biologic treatments for moderate-to-severe plaque psoriasis in the real world: a systematic review A Gambardella, G Licata, A Sohrt Dermatology and Therapy 11 (4), 1141-1156, 2021 | 17 | 2021 |
| A case of moderate hidradenitis suppurativa and psoriasis successfully treated with risankizumab. G Licata, A Gambardella, D Buononato, A De Rosa, G Calabrese, ... International Journal of Dermatology 61 (4), 2022 | 16 | 2022 |
| Successful treatment of Pityriasis rubra pilaris with brodalumab. A De Rosa, A Gambardella, G Licata, R Alfano, G Argenziano Australasian Journal of Dermatology 61 (2), 2020 | 16 | 2020 |
| Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. G Licata, A Gambardella, G Calabrese, F Pagliuca, R Alfano, ... Clinical & Experimental Dermatology 46 (8), 2021 | 12 | 2021 |
| Dupilumab and conjunctivitis: a case series of twenty patients. G Calabrese, A Gambardella, G Licata, EV Di Brizzi, R Alfano, ... Journal of the European Academy of Dermatology and Venereology, 2021 | 12 | 2021 |
| Topical and conventional systemic treatments in atopic dermatitis: have they gone out of fashion? G Calabrese, G Licata, A Gambardella, A De Rosa, R Alfano, ... Dermatology Practical & Conceptual 12 (1), 2022 | 11 | 2022 |
| Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: a case series G Licata, V Tancredi, E Pezzolo, G Pertusi, E Tolino, M Arisi, ... Journal of the European Academy of Dermatology and Venereology 37 (8), e1064 …, 2023 | 9 | 2023 |
| Reflectance confocal microscopy assessment of the depigmenting agents complex for melasma treatment M Agozzino, G Licata, CMR Giorgio, G Babino, A Lupoli, I Sperduti, ... The Journal of Clinical and Aesthetic Dermatology 13 (9), 41, 2020 | 8 | 2020 |
| Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes–from the ESC‐HFA EORP Heart … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 25 (9), 1571-1583, 2023 | 6 | 2023 |
| Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature. G Licata, GCL Danzuso, C Fiorella, G Palazzo, P Calzavara‐Pinton, ... Journal of the European Academy of Dermatology & Venereology 36 (11), 2022 | 6 | 2022 |
| Concurrent atopic dermatitis and psoriasis successfully treated with brodalumab A Gambardella, G Licata, A De Rosa, F Pagliuca, G Calabrese, R Alfano, ... Dermatitis 32 (1S), e86-e88, 2021 | 6 | 2021 |
| Bullous erysipelas caused by citrobacter koseri G Licata, A De Rosa, A Gambardella, G Calabrese, G Argenziano, ... J Clin Aesthet Dermatol 14 (5), 12, 2021 | 5 | 2021 |
| Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report. CMR Giorgio, G Briatico, G Licata, G Babino, E Fulgione, A Ronchi, ... Dermatologic Therapy 34 (2), 2021 | 5 | 2021 |
| SAPHO syndrome successful treated with tildrakizumab. G Licata, A Gambardella, G Calabrese, R Alfano, G Argenziano Dermatologic Therapy 34 (1), 2021 | 5 | 2021 |
| A case of discoid lupus erythematosus because of palbociclib. G Calabrese, G Licata, A Gambardella, A De Rosa, A Ronchi, ... Journal of Cutaneous Pathology 47 (7), 2020 | 5 | 2020 |
